Recently, IntoCare has been awarded REAL 100 Innovative Entrepreneur held by Jiemian News, which is China’s most influential digital media outlet specializing in business and finance news.
Over the weekend, following the 14thChinese Academic Congress of Colorectal Surgery in conjunction with the International Summit of Colorectal Surgery, IntoCare team is honored to attend the 4th Academic Con···
Intocare is honored to attend the 14thChinese Academic Congress of Colorectal Surgery in conjunction with the International Summit of ColoRectal Surgery. We are excited to have so many professors and doctors···
On September 9-10th, together with our distributor AspironiX, IntoCare made its first public appearance at Czech-Slovak congress of Petřivalský Rapant's Days in Olomouc, Czech Republic. The Congress fo···
On August 19th, Prof. Li Xinxiang's team from Fudan University Shanghai Cancer Center completed the first case of an enrolled patient in a multi-center clinical study of the app···
Since 1991, Minimal invasive surgery has entered in China for 30 years. Over the 30 years MIS wide-spread across China, taking over almost half of the national amount of surgery.
In 2015, Johnson & Johnson and Medtronic continued to dominate the powered stapler market. At that time, few Chinese companies kept up, but that’s when Eva Zhang, the CEO of IntoCare decided to take som···
IntoCare Powered Stapling Platform with E-Stapling Technology, offers an ergonomic, intuitive and uniformed stapling system resulting in a reduced learning curve for surgeons and simplified ease of use, and boosts confidence in consistent anastomotic integrity for a safer surgery.